Singapore markets open in 7 hours 12 minutes
Straits Times Index
3,330.01 -8.93 (-0.27%) S&P 500
5,337.42 +46.08 (+0.87%) Dow
38,745.53 +34.24 (+0.09%) Nasdaq
17,128.53 +271.49 (+1.61%) Bitcoin USD
71,491.94 +1,065.09 (+1.51%) CMC Crypto 200
1,525.48 +51.74 (+3.51%)
Gyre Therapeutics, Inc. (GYRE)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 01:28PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 930.35M |
| Enterprise value | 893.27M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 8.03 |
| Price/book (mrq) | 16.43 |
| Enterprise value/revenue | 7.72 |
| Enterprise value/EBITDA | 40.84 |
Trading information
Stock price history
| Beta (5Y monthly) | N/A |
| 52-week change 3 | 202.22% |
| S&P500 52-week change 3 | 23.99% |
| 52-week high 3 | 30.40 |
| 52-week low 3 | 3.30 |
| 50-day moving average 3 | 15.00 |
| 200-day moving average 3 | 14.57 |
Share statistics
| Avg vol (3-month) 3 | 64.14k |
| Avg vol (10-day) 3 | 83.88k |
| Shares outstanding 5 | 85.51M |
| Implied shares outstanding 6 | 85.51M |
| Float 8 | 15.72M |
| % held by insiders 1 | 81.73% |
| % held by institutions 1 | 0.96% |
| Shares short (15 May 2024) 4 | 169.64k |
| Short ratio (15 May 2024) 4 | 2.78 |
| Short % of float (15 May 2024) 4 | 2.65% |
| Short % of shares outstanding (15 May 2024) 4 | 0.20% |
| Shares short (prior month 15 Apr 2024) 4 | 181.87k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | N/A |
| Trailing annual dividend yield 3 | N/A |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 12 Jan 2023 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:15 |
| Last split date 3 | 31 Oct 2023 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | -75.76% |
| Operating margin (ttm) | 29.70% |
Management effectiveness
| Return on assets (ttm) | 11.03% |
| Return on equity (ttm) | -99.09% |
Income statement
| Revenue (ttm) | 115.69M |
| Revenue per share (ttm) | 1.63 |
| Quarterly revenue growth (yoy) | 9.00% |
| Gross profit (ttm) | N/A |
| EBITDA | 21.87M |
| Net income avi to common (ttm) | -87.64M |
| Diluted EPS (ttm) | N/A |
| Quarterly earnings growth (yoy) | 235.70% |
Balance sheet
| Total cash (mrq) | 37.35M |
| Total cash per share (mrq) | 0.44 |
| Total debt (mrq) | 275k |
| Total debt/equity (mrq) | 0.31% |
| Current ratio (mrq) | 3.22 |
| Book value per share (mrq) | N/A |
Cash flow statement
| Operating cash flow (ttm) | 18.36M |
| Levered free cash flow (ttm) | N/A |
© 2024 Yahoo. All rights reserved.